logo
16:01 Dec 05

Mercury Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
878.80
+6.00 (+0.69%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Mercury Laboratories Ltd. Financials

Mercury Laboratories Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
878.80
+6.00 (+0.69%)
16:01 Dec 05
Quality
image/svg+xml

50/100
Medium Financial Strength

Valuation
image/svg+xml

48/100
Mid Valuation

Technical

57/100
Technically Neutral

Strength

8

Weakness

5

Opportunity

0

Threats

0

5.87 %

ROE %

4.23 %

ROA %

0.00

EPS

446.41

BVPS

0.00 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
57.92 75.33 75.56 75.1 76.56
Operating Expenses +
50.81 66.77 66.53 68.08 68.8
Raw Material
23.88 30.96 30.45 29.66 30.77
Increase Decrease in Cost
-0.22 -0.55 -0.15 -0.74 -1.1
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
12.37 14.23 14.5 16.84 17.24
Miscellaneous Expenses
18.88 26.91 26.45 26.74 21.89
Operating Profit
7.11 8.56 9.03 7.02 7.76
Other Income
0.82 1.72 1.09 1.07 1.1
Depreciation
2.45 2.48 2.82 2.88 3.02
Interest
0.45 0.36 0.38 0.55 0.56
Profit before tax and exceptio..
5.03 7.44 6.92 4.66 5.28
Exceptional Items
0.13 0.05 0 0 0
PBT
5.16 7.49 6.92 4.66 5.28
Provision for Taxation
1.47 1.91 1.27 1.52 1.52
Net Profit
3.69 5.58 5.65 3.14 3.77
NET Profit after MI
0 0 0 0 0
EPS
30.72 46.49 47.12 26.21 31.42
Operating Profit Margin (%)
12.28 11.36 11.95 9.35 10.14
Net Profit Margin (%)
6.37 7.41 7.48 4.18 4.92

Mercury Laboratories Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 73.70 73.70 73.70 73.70 73.70 73.70
FII 0.00 0.00 0.00 0.00 0.00 0.00
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 26.30 26.30 26.30 26.30 26.30 26.30
Shareholder Shares Holding %
Research 360 logo
Download Our App On: